Anti Gt1a Antibody Positivity C5676724
An autoimmune condition where antibodies target GT1a gangliosides in peripheral nerves. Associated with Guillain-Barré syndrome variants affecting the throat and limbs. Treatment typically involves immunotherapy.
Key facts at a glance
- ICD-10
- G43.909
- ICD-11
- 8A00.0
- Body system
- neurologic
- Severity
- severe
- Chronic
- false
Signs and symptoms
Common signs and symptoms that may indicate this condition.
Warning signs - seek immediate care
Bulbar palsy
Autonomic dysfunction
Generalized symptoms
(neurologic)Significant symptoms that substantially affect daily functioning.
Frequency: Varies
Oropharyngeal dysphagia
(neurologic)Cervical weakness
(neurologic)Upper limb weakness
(neurologic)Diagnosis and tests
How this condition is diagnosed and what test results mean.
Initial screening tests
Standard diagnostic workup
Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]
Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]
Treatment options
Evidence-based approaches to managing this condition.
First-line treatments
Medication management with follow-up
Active treatment with regular monitoring by a healthcare provider is recommended.
Plasmapheresis
Therapeutic plasma exchange to remove circulating anti-GT1a IgM antibodies. This immunomodulatory procedure reduces antibody-mediated nerve damage and is most effective early in disease course.
High-Dose IVIG Therapy
Immunoglobulin therapy that neutralizes pathogenic antibodies and reduces immune-mediated inflammation. Standard dosing protocols are used with careful infusion rate monitoring.
Additional treatment options
Gait and Balance Training
Specialized physical therapy addressing ataxia and proprioceptive dysfunction common in GT1a antibody syndromes. Focuses on safety, independence, and functional mobility.
physical_therapyComprehensive Neurological Assessment
Regular neurological examinations including cranial nerve assessment, reflexes, sensory testing, and coordination evaluation to monitor disease progression and treatment efficacy.
monitoringEnergy Conservation Techniques
Education on pacing activities, strategic rest breaks, and adaptive equipment use to maximize function while minimizing fatigue during recovery.
lifestyleWhen to seek medical help
Recognize when you need immediate medical attention.
See a doctor within 24 hours
Moderate to severe symptoms that may indicate worsening of this condition. Prompt medical evaluation is recommended.
Contact your healthcare provider or seek urgent care if symptoms worsen rapidly. Go to the emergency department for life-threatening symptoms.
Frequently asked questions
Common questions about this topic.
What is Anti Gt1a Antibody Positivity C5676724?
Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]
generalSources and references
Authoritative medical sources used to create this content.
Willison HJ, Jacobs BC, van Doorn PA. Guidelines for the management of Guillain-Barré syndrome and variants. Lancet Neurology. 2021.
Kaida K, Ariga T, Yu RK. Anti-ganglioside antibodies and their pathophysiological effects on Guillain-Barré syndrome and related disorders. Journal of Neuroimmunology. 2019.
Chiba A, Kusunoki S, Obata H, et al. Serum anti-GT1a IgG antibody in patients with Miller Fisher syndrome and related conditions. Annals of Neurology. 2018.
Wakerley BR, Uncini A, Yuki N, et al. Guillain-Barré and Miller Fisher syndromes: an analysis of 1225 cases from a global registry. Journal of Neurology Neurosurgery and Psychiatry. 2020.
Medication Comparisons
Compare medications used to treat Anti Gt1a Antibody Positivity C5676724. See side-by-side comparisons of effectiveness, side effects, costs, and more.
View Medication ComparisonsThis information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.
If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.
Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy